MLECW

Moolec Science SA

Healthcare · USD

Set alert

Price alert · MLECW

All alert types
0.01 USD 0.00 -4.17%
As of Oct 30, 2026 Extended hours 0.01 -10.14%
Bid
0.01 × —
Ask
0.01 × —
0.0062 Day range 0.007
0.0069 52-week range 0.0069
YTD
0.00%
1 year
0.00%
Open
0.0116
Prev close
0.0072
Mkt cap
76.24K
Vol
35.04K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0062
High
0.007
Forward P/E
0.00
Beta
-0.54
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
0.00
200-d avg
0.00
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for MLECW has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.34 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.4×
FY 2020: -122125×FY 2021: -833×FY 2022: -24.5×FY 2023: -58.4×FY 2024: -0.4×
FY 2020 5y median -58.4× FY 2024
P/S 0.1×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 1401×FY 2023: 76.0×FY 2024: 0.1×
FY 2020 5y median 0.1× FY 2024
P/B -0.6×
FY 2020: 12.7×FY 2021: 2339×FY 2022: 126×FY 2023: 62.7×FY 2024: -0.6×
FY 2020 5y median 62.7× FY 2024
P/FCF -1.4×
FY 2020: -192803×FY 2021: -1990×FY 2022: -165×FY 2023: -45.0×FY 2024: -1.4×
FY 2020 5y median -165× FY 2024
EV/EBITDA -4.2×
FY 2020: -122959×FY 2021: -1028×FY 2022: -24.5×FY 2023: 30.9×FY 2024: -4.2×
FY 2020 5y median -24.5× FY 2024
EV/Sales 0.9×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 1402×FY 2023: 77.6×FY 2024: 0.9×
FY 2020 5y median 0.9× FY 2024
FCF Yield -73.9%
FY 2020: -0.0%FY 2021: -0.1%FY 2022: -0.6%FY 2023: -2.2%FY 2024: -73.9%
FY 2020 5y median -0.6% FY 2024

Profitability

Gross Margin 34.2%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -15.8%FY 2023: 8.4%FY 2024: 34.2%
FY 2020 5y median 0.0% FY 2024
Operating Margin -3.1%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -735.2%FY 2023: -160.8%FY 2024: -3.1%
FY 2020 5y median -3.1% FY 2024
Net Margin -33.4%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -5722.2%FY 2023: -130.0%FY 2024: -33.4%
FY 2020 5y median -33.4% FY 2024
ROE 169.0%
FY 2020: -0.0%FY 2021: -282.2%FY 2022: -512.5%FY 2023: -107.3%FY 2024: 169.0%
FY 2020 5y median -107.3% FY 2024
ROIC -5.3%
FY 2020: -0.0%FY 2021: -99.3%FY 2022: -47.3%FY 2023: -26.9%FY 2024: -5.3%
FY 2020 5y median -26.9% FY 2024
ROA -54.4%
FY 2020: -0.0%FY 2021: -79.5%FY 2022: -215.3%FY 2023: -21.0%FY 2024: -54.4%
FY 2020 5y median -54.4% FY 2024

Growth (YoY)

Revenue 5830.7%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 521.5%FY 2024: 5830.7%
FY 2020 FY 2024
Operating Income -15.9%
FY 2020: 0.0%FY 2021: -12339.6%FY 2022: -287.6%FY 2023: -35.9%FY 2024: -15.9%
FY 2020 FY 2024
EPS (diluted) -8978.9%
FY 2020: 0.0%FY 2021: -14900.0%FY 2022: -1150.0%FY 2023: 87.3%FY 2024: -8978.9%
FY 2020 FY 2024
Free Cash Flow -217.3%
FY 2020: 0.0%FY 2021: -21326.7%FY 2022: -307.8%FY 2023: -23.4%FY 2024: -217.3%
FY 2020 FY 2024

Financial Health

Current Ratio 0.1×
FY 2020: 0.7×FY 2021: 0.3×FY 2022: 0.4×FY 2023: 1.7×FY 2024: 0.1×
FY 2020 5y median 0.4× FY 2024
Quick Ratio 0.1×
FY 2020: 0.7×FY 2021: 0.3×FY 2022: 0.4×FY 2023: 0.9×FY 2024: 0.1×
FY 2020 5y median 0.4× FY 2024
Debt / Equity -3.7×
FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.3×FY 2023: 2.2×FY 2024: -3.7×
FY 2020 5y median 0.1× FY 2024
Net Debt / EBITDA -3.6×
FY 2020: 15.4×FY 2021: 0.3×FY 2022: -0.0×FY 2023: 0.7×FY 2024: -3.6×
FY 2020 5y median 0.3× FY 2024
Interest Coverage -0.3×
FY 2020: 0.0×FY 2021: -806×FY 2022: -41.6×FY 2023: -7.8×FY 2024: -0.3×
FY 2020 5y median -7.8× FY 2024

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2020 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2020 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2025-06-30